- Hemodialysis and peritoneal dialysis are life-sustaining treatments for patients with end-stage renal disease (ESRD), removing waste, toxins, and excess fluids from the blood when kidneys can no longer function properly
- The market growth is significantly driven by the increasing incidence of chronic kidney disease (CKD), aging population, and rising awareness about renal replacement therapies in Europe
- Germany is expected to dominate the Europe hemodialysis and peritoneal dialysis market with a market share of 23.5%, due to advanced healthcare infrastructure and increasing demand for eye surgeries
- France is expected to be the fastest growing country in the Europe hemodialysis and peritoneal dialysis market with 13.6% market share, supported by expanding healthcare access, modernization of dialysis infrastructure, and policy support for home dialysis adoption
- Hemodialysis machines segment is expected to dominate the market with a market share of 35.5% due to its critical role in renal replacement therapy and widespread use across both in-center and home dialysis settings
